TY - JOUR AU - Han, R. AU - Zhou, J. AU - François, C. AU - Toumi, M. PY - 2019 DA - 2019// TI - Prevalence of hepatitis C infection among the general population and high-risk groups in the EU/EEA: a systematic review update JO - BMC Infect Dis VL - 19 UR - https://doi.org/10.1186/s12879-019-4284-9 DO - 10.1186/s12879-019-4284-9 ID - Han2019 ER - TY - JOUR AU - Grebely, J. AU - Larney, S. AU - Peacock, A. PY - 2019 DA - 2019// TI - Global, regional, and country-level estimates of hepatitis C infection among people who have recently injected drugs JO - Addiction VL - 114 UR - https://doi.org/10.1111/add.14393 DO - 10.1111/add.14393 ID - Grebely2019 ER - TY - JOUR AU - Hellard, R. AU - Sacks-Davis, J. D. PY - 2016 DA - 2016// TI - Hepatitis C elimination by 2030 through treatment and prevention: think global, act in local networks JO - J Epidemiol Community Health VL - 70 UR - https://doi.org/10.1136/jech-2015-205454 DO - 10.1136/jech-2015-205454 ID - Hellard2016 ER - TY - JOUR AU - Martin, N. K. AU - Vickerman, P. AU - Dore, G. J. PY - 2016 DA - 2016// TI - Prioritization of HCV treatment in the direct-acting antiviral era: an economic evaluation JO - J Hepatol VL - 65 UR - https://doi.org/10.1016/j.jhep.2016.02.007 DO - 10.1016/j.jhep.2016.02.007 ID - Martin2016 ER - TY - JOUR AU - Mason, L. M. K. AU - Veldhuijzen, I. K. AU - Duffell, E. PY - 2019 DA - 2019// TI - Hepatitis B and C testing strategies in healthcare and community settings in the EU/EEA: a systematic review JO - J Viral Hepat VL - 26 UR - https://doi.org/10.1111/jvh.13182 DO - 10.1111/jvh.13182 ID - Mason2019 ER - TY - JOUR AU - Hickman, M. AU - Dillon, J. F. AU - Elliott, L. PY - 2019 DA - 2019// TI - Evaluating the population impact of hepatitis C direct acting antiviral treatment as prevention for people who inject drugs (EPIToPe)—a natural experiment (protocol) JO - BMJ Open VL - 9 UR - https://doi.org/10.1136/bmjopen-2019-029538 DO - 10.1136/bmjopen-2019-029538 ID - Hickman2019 ER - TY - JOUR AU - Jack, K. AU - Willott, S. AU - Manners, J. PY - 2009 DA - 2009// TI - Clinical trial: a primary-care-based model for the delivery of anti-viral treatment to injecting drug users infected with hepatitis C JO - Aliment Pharmacol Ther VL - 29 UR - https://doi.org/10.1111/j.1365-2036.2008.03872.x DO - 10.1111/j.1365-2036.2008.03872.x ID - Jack2009 ER - TY - JOUR AU - Santen, D. K. AU - Helm, J. J. AU - Lindenburg, K. PY - 2017 DA - 2017// TI - HIV and hepatitis C treatment uptake among people who use drugs participating in the Amsterdam Cohort Studies, 1985–2015 JO - Int J Drug Policy VL - 47 UR - https://doi.org/10.1016/j.drugpo.2017.05.026 DO - 10.1016/j.drugpo.2017.05.026 ID - Santen2017 ER - TY - JOUR AU - Beckwith, C. G. AU - Kurth, A. E. AU - Bazerman, L. B. PY - 2016 DA - 2016// TI - A pilot study of rapid hepatitis C virus testing in the Rhode island Department of Corrections JO - J Public Health (Oxf) VL - 38 UR - https://doi.org/10.1093/pubmed/fdv023 DO - 10.1093/pubmed/fdv023 ID - Beckwith2016 ER - TY - JOUR AU - Drobnik, A. C. AU - Judd, D. AU - Banach, J. PY - 2011 DA - 2011// TI - Public health implications of rapid hepatitis C screening with an oral swab for community-based organizations serving high-risk populations JO - Am J Public Health VL - 101 UR - https://doi.org/10.2105/AJPH.2011.300251 DO - 10.2105/AJPH.2011.300251 ID - Drobnik2011 ER - TY - JOUR AU - Jewett, A. AU - Smith, B. D. AU - Garfein, R. S. PY - 2012 DA - 2012// TI - Field-based performance of three pre-market rapid hepatitis C virus antibody assays in STAHR (Study to Assess Hepatitis C Risk) among young adults who inject drugs in San Diego JO - CA J Clin Virol VL - 54 UR - https://doi.org/10.1016/j.jcv.2012.04.003 DO - 10.1016/j.jcv.2012.04.003 ID - Jewett2012 ER - TY - JOUR AU - Williams, B. AU - Howell, J. AU - Doyle, J. PY - 2019 DA - 2019// TI - Point-of-care hepatitis C testing from needle and syringe programs: an Australian feasibility study JO - Int J Drug Policy VL - 72 UR - https://doi.org/10.1016/j.drugpo.2019.05.012 DO - 10.1016/j.drugpo.2019.05.012 ID - Williams2019 ER - TY - JOUR AU - Latham, N. H. AU - Pedrana, A. AU - Doyle, J. S. PY - 2019 DA - 2019// TI - Community-based, point-of-care hepatitis C testing: perspectives and preferences of people who inject drugs JO - J Viral Hepat VL - 26 UR - https://doi.org/10.1111/jvh.13087 DO - 10.1111/jvh.13087 ID - Latham2019 ER - TY - JOUR AU - Uuskula, A. AU - Kalikova, N. AU - Zilmer, K. PY - 2002 DA - 2002// TI - The role of injection drug use in the emergence of Human Immunodeficiency Virus infection in Estonia JO - Int J Infect Dis VL - 6 UR - https://doi.org/10.1016/s1201-9712(02)90131-1 DO - 10.1016/s1201-9712(02)90131-1 ID - Uuskula2002 ER - TY - JOUR AU - Tavitian-Exley, I. AU - Maheu-Giroux, M. AU - Platt, L. PY - 2018 DA - 2018// TI - Differences in risk behaviours and HIV status between primary amphetamines and opioid injectors in Estonia and Russia JO - Int J Drug Policy VL - 53 UR - https://doi.org/10.1016/j.drugpo.2017.11.010 DO - 10.1016/j.drugpo.2017.11.010 ID - Tavitian-Exley2018 ER - TY - STD TI - Centers for Disease Control and Prevention. National HIV Behavioral Surveillance System in Injecting Drug Users—Round 3: Operations Manual. May 25, 2012. https://www.cdc.gov/hiv/statistics/systems/nhbs/operations.html. Accessed on June 4, 2020. UR - https://www.cdc.gov/hiv/statistics/systems/nhbs/operations.html ID - ref16 ER - TY - JOUR AU - Tang, W. AU - Chen, W. AU - Amini, A. PY - 2017 DA - 2017// TI - Diagnostic accuracy of tests to detect Hepatitis C antibody: a meta-analysis and review of the literature JO - BMC Infect Dis VL - 17 UR - https://doi.org/10.1186/s12879-017-2773-2 DO - 10.1186/s12879-017-2773-2 ID - Tang2017 ER - TY - JOUR AU - Degenhardt, L. AU - Peacock, A. AU - Colledge, S. PY - 2017 DA - 2017// TI - Global prevalence of injecting drug use and sociodemographic characteristics and prevalence of HIV, HBV, and HCV in people who inject drugs: a multistage systematic review JO - Lancet Glob Health VL - 5 UR - https://doi.org/10.1016/S2214-109X(17)30375-3 DO - 10.1016/S2214-109X(17)30375-3 ID - Degenhardt2017 ER - TY - STD TI - Implementing HIV testing in nonclinical settings a guide for HIV testing providers. CDC 2016. https://www.cdc.gov/hiv/pdf/testing/cdc_hiv_implementing_hiv_testing_in_nonclinical_settings.pdf . Accessed on June 4, 2020. UR - https://www.cdc.gov/hiv/pdf/testing/cdc_hiv_implementing_hiv_testing_in_nonclinical_settings.pdf ID - ref19 ER - TY - JOUR AU - Crucitti, T. AU - Taylor, D. AU - Beelaert, G. PY - 2011 DA - 2011// TI - Performance of a rapid and simple HIV testing algorithm in a multicenter phase III microbicide clinical trial JO - Clin Vaccine Immunol VL - 18 UR - https://doi.org/10.1128/CVI.05069-11 DO - 10.1128/CVI.05069-11 ID - Crucitti2011 ER - TY - JOUR AU - Everett, D. B. AU - Baisley, K. AU - Changalucha, J. PY - 2009 DA - 2009// TI - Suitability of simple human immunodeficiency virus rapid tests in clinical trials in community-based clinic settings JO - J Clin Microbiol VL - 47 UR - https://doi.org/10.1128/JCM.01998-08/ DO - 10.1128/JCM.01998-08/ ID - Everett2009 ER - TY - JOUR AU - Waheed, U. AU - Hayat, K. AU - Ahmad, B. PY - 2013 DA - 2013// TI - Evaluation of HIV/AIDS diagnostics kits and formulation of a testing strategy for Pakistan JO - J Clin Virol VL - 56 UR - https://doi.org/10.1016/j.jcv.2012.12.012 DO - 10.1016/j.jcv.2012.12.012 ID - Waheed2013 ER - TY - JOUR AU - Fourati, S. AU - Feld, J. J. AU - Chevaliez, S. PY - 2018 DA - 2018// TI - Approaches for simplified HCV diagnostic algorithms JO - J Int AIDS Soc VL - 21 UR - https://doi.org/10.1002/jia2.25058 DO - 10.1002/jia2.25058 ID - Fourati2018 ER - TY - JOUR AU - Parry, J. V. AU - Easterbrook, P. AU - Sands, A. R. PY - 2017 DA - 2017// TI - One or two serological assay testing strategy for diagnosis of HBV and HCV infection? The use of predictive modelling JO - BMC Infect Dis VL - 17 UR - https://doi.org/10.1186/s12879-017-2774-1 DO - 10.1186/s12879-017-2774-1 ID - Parry2017 ER - TY - JOUR AU - Wu, S. Z. AU - Wei, J. L. AU - Xu, B. PY - 2017 DA - 2017// TI - Detection and analysis of hepatitis C virus in HIV-infected patients in the Guangxi province of China JO - Exp Ther Med VL - 13 UR - https://doi.org/10.3892/etm.2017.4067 DO - 10.3892/etm.2017.4067 ID - Wu2017 ER - TY - JOUR AU - Juniastuti, T. U. AU - Nasronudin, L. A. PY - 2014 DA - 2014// TI - High rate of seronegative HCV infection in HIV-positive patients JO - Biomed Rep VL - 2 UR - https://doi.org/10.3892/br.2013.188 DO - 10.3892/br.2013.188 ID - Juniastuti2014 ER - TY - JOUR AU - Smith, B. D. AU - Drobeniuc, J. AU - Jewett, A. PY - 2011 DA - 2011// TI - Evaluation of Three rapid screening assays for detection of antibodies to hepatitis C virus JO - J Inf Dis VL - 204 UR - https://doi.org/10.1093/infdis/jir422 DO - 10.1093/infdis/jir422 ID - Smith2011 ER - TY - JOUR AU - Trooskin, S. B. AU - Poceta, J. AU - Towey, C. M. PY - 2015 DA - 2015// TI - Results from a geographically focused, community-based HCV screening, linkage-to-care and patient navigation program JO - J Gen Intern Med VL - 30 UR - https://doi.org/10.1007/s11606-015-3209-6 DO - 10.1007/s11606-015-3209-6 ID - Trooskin2015 ER - TY - JOUR AU - Morano, J. P. AU - Zelenev, A. AU - Lombard, A. PY - 2014 DA - 2014// TI - Strategies for hepatitis C testing and linkage to care for vulnerable populations: point-of-care and standard HCV testing in a mobile medical clinic JO - J Community Health VL - 39 UR - https://doi.org/10.1007/s10900-014-9932-9 DO - 10.1007/s10900-014-9932-9 ID - Morano2014 ER - TY - JOUR AU - Hayes, B. AU - Briceno, A. AU - Asher, A. PY - 2014 DA - 2014// TI - Preference, acceptability and implications of the rapid hepatitis C screening test among high-risk young people who inject drugs JO - BMC Public Health VL - 14 UR - https://doi.org/10.1186/1471-2458-14-645 DO - 10.1186/1471-2458-14-645 ID - Hayes2014 ER - TY - JOUR AU - Barocas, J. A. AU - Linas, B. P. AU - Kim, A. Y. PY - 2016 DA - 2016// TI - Acceptability of rapid point-of-care hepatitis C tests among people who inject drugs and utilize syringe-exchange programs JO - Open Forum Infect Dis VL - 3 UR - https://doi.org/10.1093/ofid/ofw075 DO - 10.1093/ofid/ofw075 ID - Barocas2016 ER - TY - JOUR AU - Smith, B. D. AU - Teshale, E. AU - Jewett, A. PY - 2011 DA - 2011// TI - Performance of premarket rapid hepatitis C virus antibody assays in 4 national human immunodeficiency virus behavioral surveillance system sites JO - Clin Infect Dis VL - 53 UR - https://doi.org/10.1093/cid/cir499 DO - 10.1093/cid/cir499 ID - Smith2011 ER - TY - JOUR AU - Tilborg, M. AU - Al Marzooqi, S. H. AU - Wong, W. W. L. PY - 2018 DA - 2018// TI - HCV core antigen as an alternative to HCV RNA testing in the era of direct-acting antivirals: retrospective screening and diagnostic cohort studies JO - Lancet Gastroenterol Hepatol VL - 3 UR - https://doi.org/10.1016/S2468-1253(18)30271-1 DO - 10.1016/S2468-1253(18)30271-1 ID - Tilborg2018 ER - TY - JOUR AU - Millbourn, C. AU - Lybeck, C. AU - Psaros Einberg, A. PY - 2020 DA - 2020// TI - Anti-HCV prevalence and risk factor-based screening for hepatitis C in pregnant women and their partners in Sweden JO - Infect Dis (Lond) VL - 52 UR - https://doi.org/10.1080/23744235.2020.1784456 DO - 10.1080/23744235.2020.1784456 ID - Millbourn2020 ER - TY - JOUR AU - Harris, A. M. AU - Chokoshvili, O. AU - Biddle, J. PY - 2019 DA - 2019// TI - An evaluation of the hepatitis C testing, care and treatment program in the country of Georgia's corrections system, December 2013–April 2015 JO - BMC Public Health VL - 19 UR - https://doi.org/10.1186/s12889-019-6783-4 DO - 10.1186/s12889-019-6783-4 ID - Harris2019 ER - TY - JOUR AU - Kinkel, H. T. AU - Karmacharya, D. AU - Shakya, J. PY - 2015 DA - 2015// TI - Prevalence of HIV, hepatitis B and C infections and an assessment of HCV-genotypes and two IL28B SNPs among people who inject drugs in three regions of Nepal JO - PLoS ONE VL - 10 UR - https://doi.org/10.1371/journal.pone.0134455 DO - 10.1371/journal.pone.0134455 ID - Kinkel2015 ER - TY - JOUR AU - Lidman, C. AU - Norden, L. AU - Kåberg, M. PY - 2009 DA - 2009// TI - Hepatitis C infection among injection drug users in Stockholm Sweden: prevalence and gender JO - Scand J Infect Dis. VL - 41 UR - https://doi.org/10.1080/00365540903062143 DO - 10.1080/00365540903062143 ID - Lidman2009 ER -